therapeutic preparations for the treatment of respiratory diseases and disorders; therapeutic preparations for the treatment of COVID-19; therapeutic preparations, namely, antibodies for the purpose of targeting the CCR5 cell receptor of cells and inhibiting or blocking the channel signaling of the CCR5 cell receptor for medical treatment

therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor, for preventing and/or treating HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, respiratory diseases and disorders; therapeutic preparations for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, respiratory diseases and disorders; therapeutic preparations for the treatment of COVID-19

Therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor, for treating HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis; therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis